spacer
spacer

PDBsum entry 1d3v

Go to PDB code: 
protein ligands metals links
Hydrolase PDB id
1d3v

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
308 a.a. *
Ligands
ABH ×2
Metals
_MN ×4
Waters ×297
* Residue conservation analysis
PDB id:
1d3v
Name: Hydrolase
Title: Crystal structure of the binuclear manganese metalloenzyme arginase complexed with 2(s)-amino-6-boronohexanoic acid, an l-arginine analog
Structure: Protein (arginase). Chain: a, b. Engineered: yes
Source: Rattus norvegicus. Norway rat. Organism_taxid: 10116. Organ: liver. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Trimer (from PDB file)
Resolution:
1.70Å     R-factor:   0.157     R-free:   0.179
Authors: J.D.Cox,N.N.Kim,A.M.Traish,D.W.Christianson
Key ref:
J.D.Cox et al. (1999). Arginase-boronic acid complex highlights a physiological role in erectile function. Nat Struct Biol, 6, 1043-1047. PubMed id: 10542097 DOI: 10.1038/14929
Date:
01-Oct-99     Release date:   17-Nov-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P07824  (ARGI1_RAT) -  Arginase-1 from Rattus norvegicus
Seq:
Struc:
323 a.a.
308 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.5.3.1  - arginase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
Urea Cycle and Arginine Biosynthesis
      Reaction: L-arginine + H2O = urea + L-ornithine
L-arginine
+ H2O
=
urea
Bound ligand (Het Group name = ABH)
matches with 57.14% similarity
+ L-ornithine
      Cofactor: Mn(2+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1038/14929 Nat Struct Biol 6:1043-1047 (1999)
PubMed id: 10542097  
 
 
Arginase-boronic acid complex highlights a physiological role in erectile function.
J.D.Cox, N.N.Kim, A.M.Traish, D.W.Christianson.
 
  ABSTRACT  
 
The crystal structure of the complex between the binuclear manganese metalloenzyme arginase and the boronic acid analog of L-arginine, 2(S)-amino-6-boronohexanoic acid (ABH), has been determined at 1.7 A resolution from a crystal perfectly twinned by hemihedry. ABH binds as the tetrahedral boronate anion, with one hydroxyl oxygen symmetrically bridging the binuclear manganese cluster and a second hydroxyl oxygen coordinating to Mn2+A. This binding mode mimics the transition state of a metal-activated hydroxide mechanism. This transition state structure differs from that occurring in NO biosynthesis, thereby explaining why ABH does not inhibit NO synthase. We also show that arginase activity is present in the penis. Accordingly, the tight binding and specificity of ABH allows us to probe the physiological role of arginase in modulating the NO-dependent smooth muscle relaxation required for erection. Strikingly, ABH causes significant enhancement of nonadrenergic, noncholinergic nerve-mediated relaxation of penile corpus cavernosum smooth muscle, suggesting that arginase inhibition sustains L-arginine concentrations for NO synthase activity. Therefore, human penile arginase is a potential target for therapeutic intervention in the treatment of erectile dysfunction.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. L-Arginine catabolism. a, Structure-based mechanism of arginase^16, in which metal-activated hydroxide ion attacks the substrate guanidinium group to form a tetrahedral intermediate (for clarity, only the side chain atoms of substrate L-arginine are shown). Proton transfer mediated by Asp 128 facilitates collapse of this intermediate to form products L-ornithine and urea. Following product dissociation, a nucleophilic metal-bridging hydroxide ion is regenerated from a metal-bridging water by proton transfer to bulk solvent. His 141 may function as a proton shuttle as indicated. b, Reciprocal coordination of arginase and nitric oxide pathways; note that N^ -hydroxy-L-arginine is an intermediate in the NO synthase reaction. c, The arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) is an isostere of L-arginine.
Figure 2.
Figure 2. Arginase−ABH complex. a, Omit electron density map of ABH in the arginase active site averaged over the two monomers in the asymmetric unit and averaged over the two twin domains A and B as described in the text. The map is contoured at 7.7 and selected active site residues are indicated. Atoms are color-coded as follows: C = yellow, O = red, N = blue, B = pale green; water molecules appear as red spheres. This figure was generated with BOBSCRIPT and Raster3D^34, ^35. b, Summary of arginase−ABH interactions; manganese coordination interactions are designated by green dashed lines, and hydrogen bonds are indicated by black dashed lines. c, Stabilization of the tetrahedral intermediate (and flanking transition states) in the arginase mechanism based on the binding mode of ABH.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: Nat Struct Biol (1999, 6, 1043-1047) copyright 1999.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20226211 D.Schade, J.Kotthaus, and B.Clement (2010).
Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease.
  Pharmacol Ther, 126, 279-300.  
20807329 H.A.Toque, M.J.Romero, R.C.Tostes, A.Shatanawi, S.Chandra, Z.N.Carneiro, E.W.Inscho, R.C.Webb, R.B.Caldwell, and R.W.Caldwell (2010).
p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.
  J Sex Med, 7, 3857-3867.  
20153713 L.Di Costanzo, M.Ilies, K.J.Thorn, and D.W.Christianson (2010).
Inhibition of human arginase I by substrate and product analogues.
  Arch Biochem Biophys, 496, 101-108.
PDB codes: 3kv2 3lp4 3lp7
19093830 E.Y.Shishova, L.Di Costanzo, F.A.Emig, D.E.Ash, and D.W.Christianson (2009).
Probing the specificity determinants of amino acid recognition by arginase.
  Biochemistry, 48, 121-131.
PDB codes: 3e6k 3e6v 3e8q 3e8z 3e9b
19465935 G.J.Ahn, H.K.Chung, C.H.Lee, K.K.Kang, and B.O.Ahn (2009).
Increased expression of the nitric oxide synthase gene and protein in corpus cavernosum by repeated dosing of udenafil in a rat model of chemical diabetogenesis.
  Asian J Androl, 11, 435-442.  
19288480 M.Leopoldini, N.Russo, and M.Toscano (2009).
Determination of the catalytic pathway of a manganese arginase enzyme through density functional investigation.
  Chemistry, 15, 8026-8036.  
17680661 D.Mavri-Damelin, L.H.Damelin, S.Eaton, M.Rees, C.Selden, and H.J.Hodgson (2008).
Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia.
  Biotechnol Bioeng, 99, 644-651.  
18360740 D.P.Dowling, L.Di Costanzo, H.A.Gennadios, and D.W.Christianson (2008).
Evolution of the arginase fold and functional diversity.
  Cell Mol Life Sci, 65, 2039-2055.  
18269446 H.Masuda (2008).
Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction.
  Int J Urol, 15, 128-134.  
  18719233 L.Santhanam, D.W.Christianson, D.Nyhan, and D.E.Berkowitz (2008).
Arginase and vascular aging.
  J Appl Physiol, 105, 1632-1642.  
16775612 B.Musicki, and A.L.Burnett (2007).
Endothelial dysfunction in diabetic erectile dysfunction.
  Int J Impot Res, 19, 129-138.  
17469833 L.Di Costanzo, M.E.Pique, and D.W.Christianson (2007).
Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster.
  J Am Chem Soc, 129, 6388-6389.
PDB codes: 2pha 2pho 2zav
17562323 L.Di Costanzo, M.Moulin, M.Haertlein, F.Meilleur, and D.W.Christianson (2007).
Expression, purification, assay, and crystal structure of perdeuterated human arginase I.
  Arch Biochem Biophys, 465, 82-89.
PDB code: 2pll
17850365 M.Ghasemi, H.Sadeghipour, and A.R.Dehpour (2007).
Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors.
  BJU Int, 100, 1385-1390.  
16409620 H.Maarsingh, J.Leusink, I.S.Bos, J.Zaagsma, and H.Meurs (2006).
Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma.
  Respir Res, 7, 6.  
16537391 J.Steppan, S.Ryoo, K.H.Schuleri, C.Gregg, R.K.Hasan, A.R.White, L.J.Bugaj, M.Khan, L.Santhanam, D.Nyhan, A.A.Shoukas, J.M.Hare, and D.E.Berkowitz (2006).
Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism.
  Proc Natl Acad Sci U S A, 103, 4759-4764.  
16675494 L.A.Holowatz, C.S.Thompson, and W.L.Kenney (2006).
L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin.
  J Physiol, 574, 573-581.  
17212779 R.Alarcón, M.S.Orellana, B.Neira, E.Uribe, J.R.García, and N.Carvajal (2006).
Mutational analysis of substrate recognition by human arginase type I--agmatinase activity of the N130D variant.
  FEBS J, 273, 5625-5631.  
16790931 R.C.Hillig, and L.Renault (2006).
Detecting and overcoming hemihedral twinning during the MIR structure determination of Rna1p.
  Acta Crystallogr D Biol Crystallogr, 62, 750-765.
PDB code: 2ca6
15748286 H.Maarsingh, M.A.Tio, J.Zaagsma, and H.Meurs (2005).
Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation.
  Respir Res, 6, 23.  
16141327 L.Di Costanzo, G.Sabio, A.Mora, P.C.Rodriguez, A.C.Ochoa, F.Centeno, and D.W.Christianson (2005).
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response.
  Proc Natl Acad Sci U S A, 102, 13058-13063.
PDB codes: 1wva 2aeb
16128822 V.López, R.Alarcón, M.S.Orellana, P.Enríquez, E.Uribe, J.Martínez, and N.Carvajal (2005).
Insights into the interaction of human arginase II with substrate and manganese ions by site-directed mutagenesis and kinetic studies. Alteration of substrate specificity by replacement of Asn149 with Asp.
  FEBS J, 272, 4540-4548.  
15355972 H.J.Ahn, K.H.Kim, J.Lee, J.Y.Ha, H.H.Lee, D.Kim, H.J.Yoon, A.R.Kwon, and S.W.Suh (2004).
Crystal structure of agmatinase reveals structural conservation and inhibition mechanism of the ureohydrolase superfamily.
  J Biol Chem, 279, 50505-50513.
PDB codes: 1wog 1woh 1woi
12647314 W.Yang, X.Gao, and B.Wang (2003).
Boronic acid compounds as potential pharmaceutical agents.
  Med Res Rev, 23, 346-368.  
12023942 H.Meurs, S.McKay, H.Maarsingh, M.A.Hamer, L.Macic, N.Molendijk, and J.Zaagsma (2002).
Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness.
  Br J Pharmacol, 136, 391-398.  
12394775 R.K.Johansson, M.Poljakovic, K.E.Andersson, and K.Persson (2002).
Expression of nitric oxide synthase in bladder smooth muscle cells: regulation by cytokines and L-arginine.
  J Urol, 168, 2280-2285.  
12055339 S.M.Morris (2002).
Regulation of enzymes of the urea cycle and arginine metabolism.
  Annu Rev Nutr, 22, 87.  
11478904 D.M.Colleluori, and D.E.Ash (2001).
Classical and slow-binding inhibitors of human type II arginase.
  Biochemistry, 40, 9356-9362.  
11258879 N.N.Kim, J.D.Cox, R.F.Baggio, F.A.Emig, S.K.Mistry, S.L.Harper, D.W.Speicher, S.M.Morris, D.E.Ash, A.Traish, and D.W.Christianson (2001).
Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum.
  Biochemistry, 40, 2678-2688.
PDB code: 1hq5
10889028 C.Moali, M.Brollo, J.Custot, M.A.Sari, J.L.Boucher, D.J.Stuehr, and D.Mansuy (2000).
Recognition of alpha-amino acids bearing various C=NOH functions by nitric oxide synthase and arginase involves very different structural determinants.
  Biochemistry, 39, 8208-8218.  
10952667 H.Meurs, M.A.Hamer, S.Pethe, S.Vadon-Le Goff, J.L.Boucher, and J.Zaagsma (2000).
Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.
  Br J Pharmacol, 130, 1793-1798.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer